spacer
home > pmps > summer 2002 > aluminium foil - a versatile tool for pharmaceutical packaging
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Aluminium Foil - A Versatile Tool for Pharmaceutical Packaging

Aluminium foil (alufoil) has been a primary material used in the protective packaging of pharmaceutical tablets since the introduction of the double-sided 'strip' pack in the 1950s. Since then, it has been an important means of protection and single unit presentation of compressed tablets and, more recently, of an enormous variety of new pharmaceutical products.

As medical and pharmaceutical science progresses, so must the packaging solutions essential to the task of delivering drugs to the point of use. A good example of this is the use of an alufoil laminated blister pack as a mould for forming tablets which are dosed into the foil tray in aqueous form and then freeze dried. Increasing demands for tamper evidence, anti-counterfeit measures and child-resistant access are all being successfully addressed by alufoil-based packaging.

There are several reasons why alufoil has gained such a strong position in the pharmaceutical packaging market, these include:


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Stefan Glimm, Secretary General of the European Aluminium Foil Association A Political Economist by discipline, Stefan Glimm has been Executive Director of the Gesamtverband der Aluminiumindustrie e.V. (GDA - the German Aluminium Industry Association) since 1992. He was appointed Secretary General of the European Aluminium Foil Association (EAFA) in 2000 having also worked with that association for several years.
He has previously been active in various capacities at the Wirtschaftvereinigung Metalle e.V. (WVM - the German Metals Federation), the European Aluminium Association (EAA) and the United Nations Environment Programme (UNEP).

spacer
Stefan Glimm
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Mr Turhan Ozen Chief Cargo Officer at Turkish Airlines elected to the International Air Cargo Association (TIACA) Committee

Turhan Ozen, serving as Chief Cargo Officer at the global brand Turkish Airlines, was elected to the International Air Cargo Association (TIACA) Committee, the joint voice of the industry that aims to enhance the air cargo profile with intensive efforts towards the global standards.
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement